Results
1 -
10 of
10Industrial Synthesis Design with Low Environmental Impact in the Pharma Industry, New Methodologies and Techniques for a Sustainable Organic Chemistry Catalysis: A key technology for a green approach to pharmaceutical production, Rendiconti Lincei The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates, Cancer Chemotherapy and Pharmacology Isolation of highly pure erlotinib hydrochloride by recrystallization after nucleophilic substitution of an impurity with piperazine, Research on Chemical Intermediates TRUST-Studie: Praxisrelevante Daten zu Erlotinib beim NSCLC, Wiener Medizinische Wochenschrift Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice, European Journal of Drug Metabolism and Pharmacokinetics Identification of putative drug targets for human sperm-egg interaction defect using protein network approach, BMC Systems Biology Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances [Online], Thieme: Stuttgart, (2005)..
Erlotinib hydrochloride, Pharmaceutical Substances